These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8065608

  • 21. [Amyloid fibril formation of beta 2-microglobulin].
    Goto Y, Hoshino M.
    Tanpakushitsu Kakusan Koso; 2002 May; 47(6):663-9. PubMed ID: 11995332
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
    Jaradat MI, Moe SM.
    Semin Dial; 2001 May; 14(2):107-12. PubMed ID: 11264777
    [Abstract] [Full Text] [Related]

  • 25. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J.
    Przegl Lek; 2006 May; 63(7):567-72. PubMed ID: 17203811
    [Abstract] [Full Text] [Related]

  • 26. Detection of fragments of beta2-microglobulin in amyloid fibrils.
    Stoppini MS, Arcidiaco P, Mangione P, Giorgetti S, Brancaccio D, Bellotti V.
    Kidney Int; 2000 Jan; 57(1):349-50. PubMed ID: 10712117
    [No Abstract] [Full Text] [Related]

  • 27. Can the nephrologist prevent dialysis-related amyloidosis?
    Zingraff J, Drüeke T.
    Am J Kidney Dis; 1991 Jul; 18(1):1-11. PubMed ID: 2063840
    [Abstract] [Full Text] [Related]

  • 28. Dialysis-related amyloidosis and high-flux membranes.
    Floege J, Smeby L.
    Contrib Nephrol; 1992 Jul; 96():124-37. PubMed ID: 1740047
    [No Abstract] [Full Text] [Related]

  • 29. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007 Jul; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 30. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
    Hardouin P, Flipo RM, Foissac-Gegoux P, Dumont A, Duquesnoy B, Delcambre B.
    Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
    [Abstract] [Full Text] [Related]

  • 31. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM, Jaber BL.
    Semin Dial; 2006 Mar; 19(2):105-9. PubMed ID: 16551286
    [Abstract] [Full Text] [Related]

  • 32. Dialysis amyloidosis.
    van Ypersele de Strihou C, Honhon B, Vandenbroucke JM, Huaux JP, Noël H, Maldague B.
    Adv Nephrol Necker Hosp; 1988 Mar; 17():401-21. PubMed ID: 3124550
    [No Abstract] [Full Text] [Related]

  • 33. A case report of severe visceral beta2-microglobulin-derived amyloidosis without obvious joint symptoms or radiological findings in a chronic hemodialyzed patient with systemic lupus erythematosus.
    Koda R, Yamazaki H, Kazama J, Ito T, Saeki T, Emura I, Miyamura S, Narita I, Gejyo F.
    Ther Apher Dial; 2009 Jun; 13(3):232-7. PubMed ID: 19527472
    [Abstract] [Full Text] [Related]

  • 34. Dialysis associated β2-microglobulin amyloidosis occurs even in the era of high-flux dialyzers.
    Falke LL, Maas SLN, Rosati S, Logtenberg SJJ.
    Amyloid; 2018 Dec; 25(4):265-266. PubMed ID: 30661416
    [No Abstract] [Full Text] [Related]

  • 35. Skeletal amyloidosis due to beta microglobulinemia in a patient on hemodialysis. A case report.
    Hadjipavlou A, Lander P, Begin L, Bercovitch D, Davidman M, Jakab E.
    J Bone Joint Surg Am; 1988 Jan; 70(1):119-21. PubMed ID: 3275669
    [No Abstract] [Full Text] [Related]

  • 36. Beta-2-microglobulin: a possible new uremic toxin?
    Gejyo F, Brancaccio D.
    Int J Artif Organs; 1988 Jan; 11(1):3-5. PubMed ID: 3283056
    [No Abstract] [Full Text] [Related]

  • 37. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S, Cambi V.
    Contrib Nephrol; 1999 Jun; 125():96-110. PubMed ID: 9895434
    [No Abstract] [Full Text] [Related]

  • 40. beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type.
    Van Ypersele de Strihou C.
    Nephrol Dial Transplant; 1996 Jun; 11 Suppl 2():147-9. PubMed ID: 8804017
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.